0

Docetaxel

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP114977285
CAS114977-28-5
Structure
MDL NumberMFCD00800737
Molecular Weight807.88
InChI KeyZDZOTLJHXYCWBA-VCVYQWHSSA-N
Descriptionpurum, ≥97.0% (HPLC)
Assay≥97.0% (HPLC)
Gradepurum
Impurity Content~6% water
MP186-192 °C (dec.)
Size5MG25MG
1

A Randomised Phase II Trial of Docetaxel Versus Docetaxel Plus Carboplatin in Patients With Castration-Resistant Prostate Cancer Who Have Progressed After Response to Prior Docetaxel Chemotherapy: The RECARDO Trial

Esther W Bouman-Wammes, H Pieter van den Berg, Linda de Munck, Aart Beeker, Carolien H Smorenburg, Walter L Vervenne, Juleon L L M Coenen, Henk M W Verheul, Winald R Gerritsen, Alfons J M Van den Eertwegh

Eur J Cancer. 2018 Feb;90:1-9.

PMID: 29268139

1

Effect of FAK Inhibitor VS-6063 (Defactinib) on Docetaxel Efficacy in Prostate Cancer

Hui-Ming Lin, Brian Y Lee, Lesley Castillo, Calan Spielman, Judith Grogan, Nicole K Yeung, James G Kench, Phillip D Stricker, Anne-Maree Haynes, Margaret M Centenera, Lisa M Butler, S Martin Shreeve, Lisa G Horvath, etc.

Prostate. 2018 Mar;78(4):308-317.

PMID: 29314097

1

Effects of Prednisone on Docetaxel Pharmacokinetics in Men With Metastatic Prostate Cancer: A Randomized Drug-Drug Interaction Study

Bodine P S Belderbos, Koen G A M Hussaarts, Leonie J van Harten, Esther Oomen-de Hoop, Peter de Bruijn, Paul Hamberg, Robbert J van Alphen, Brigitte C M Haberkorn, Martijn P Lolkema, Ronald de Wit, Robert J van Soest, etc.

Br J Clin Pharmacol. 2019 May;85(5):986-992.

PMID: 30737835

1

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 [Corrected]

Robert G Maki, J Kyle Wathen, Shreyaskumar R Patel, Dennis A Priebat, Scott H Okuno, Brian Samuels, Michael Fanucchi, David C Harmon, Scott M Schuetze, Denise Reinke, Peter F Thall, Robert S Benjamin, Laurence H Baker, etc.

J Clin Oncol. 2007 Jul 1;25(19):2755-63.

PMID: 17602081

1

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial

Pasi A Jänne, Michel M van den Heuvel, Fabrice Barlesi, Manuel Cobo, Julien Mazieres, Lucio Crinò, Sergey Orlov, Fiona Blackhall, Juergen Wolf, Pilar Garrido, Artem Poltoratskiy, Gabriella Mariani, Dana Ghiorghiu, etc.

JAMA. 2017 May 9;317(18):1844-1853.

PMID: 28492898

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode